ILC1 can block viral, intracellular bacterial, and fungal infection through secreting IFN-γ, but ILC1 could also promote COPD, IBD, and cancer in response to different stimuli [23, 24, 38–40]. Here, IFNG is linked to chronic obstructive pulmonary disease.